Anti-TNF scintigraphy to assess TNF-α-associated joint inflammation in rheumatoid arthritis and osteoarthritis

Clinical and Experimental Rheumatology

Volumn 32, Issue 4, 2014, Pages 614-

  Hermann, Josef ^a,b   Lipp, R W ^b   Dunzinger, A ^b,c   Spreizer, C ^b   Schaffler, G ^b,d   Kvaternik, H ^b   Ofner, P ^b   Graninger, W ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c AKH Linz   (Austria)

^d Hospital Brothers of St John   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLOROQUINE; GADOLINIUM; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; TECHNETIUM 99M; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRITIS; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EDITORIAL; FEMALE; HUMAN; IMAGE ANALYSIS; JOINT EFFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; TREATMENT DURATION; WHOLE BODY SCINTISCANNING;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; JOINTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SYNOVITIS; TECHNETIUM; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER; WHOLE BODY IMAGING;

EID: 84904917706     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. LIPSKY PE, van der HEIJDE DM, st CLAIR EW et al.: Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000; 343: 1594-602.
2. ANNOVAZZI A, ALESSANDRIA C, CAPRILLI R et al.: Radiolabelling of monoclonal anti-TNF antibody with 99mTc: in vitro studies. J Nucl Med 2002; 46: 27 (abstract)
3. FURUZAWA-CARBALLEDA J, MACIP-RODRIGUEZ PM, CABRAL AR: Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Clin Exp Rheumatol 2008; 26: 554-60.
4. ROIMICHER L, LOPES FP, de SOUZA SA et al.: 99mTc-anti-TNF-{alpha} scintigraphy in RA: a comparison pilot study with MRI and clinical examination. Rheumatology (Oxford) 2011; 50: 2044-50.
5. OSTERGAARD M, PETERFY C, CONAGHAN P et al.: OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003; 30: 1385-6.
6. TAKEUCHI T, MIYASAKA N, TATSUKI Y et al.: Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1208-15.
7. TETTA C, CAMUSSI G, MODENA V, DI VITTORIO C, BAGLIONI C: Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 1990; 49: 665-7.
8. CECCARELLI F, PERRICONE C, TROTTA F et al.: Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva). Clin Exp Rheumatol 2013; 31: 341-9.